A new method of computer-aided evaluation makes it easier to differentiate between benign and malignant lesions on MR scans, possibly reducing the number of false positives and unnecessary biopsies.
Other findings include:
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.